
Vexirab IT 20mg/150mg Capsule
Marketer
Vexilla Healthcare
Salt Composition
Rabeprazole (20mg) + Itopride (150mg)
Overview Vexirab IT 20mg/150mg Capsule
Gastro-esophageal reflux disease (GERD) and peptic ulcer symptoms, including heartburn, stomach upset, and discomfort, are addressed by the dual-action formulation, Acidex Duo 20mg/150mg capsules. This medication neutralizes stomach acid and facilitates gas expulsion, easing indigestion. Acidex Duo is administered as prescribed, with or without food, for the duration recommended by your physician; dosage is individualized based on your response. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is essential, as interactions are possible. Common, typically transient, side effects include abdominal pain, altered bowel habits (diarrhea or constipation), headache, flatulence, fatigue, and hypersalivation. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid driving or activities requiring alertness until their impact is known. Alcohol consumption should be avoided due to potential additive sedation. Lifestyle adjustments, such as consuming cold milk and avoiding stimulants like coffee, tea, and spicy or chocolate-rich foods, may enhance treatment outcomes. Prior to initiating Acidex Duo, individuals with liver conditions, pregnant or breastfeeding women, and those planning pregnancy should inform their physician.
Uses of Vexirab IT 20mg/150mg Capsule
Stomach acid reflux (GERD) and peptic ulcers
Major Benefits of Vexirab IT 20mg/150mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for Vexirab IT 20mg/150mg Capsules. Administer on an empty stomach.
Common Side effects of Vexirab IT 20mg/150mg Capsule:
- Stomach pain
- Diarrhea
- Constipation
- Headache
- Dizziness
- Flatulence
- Weakness
- Flu-like symptoms
- Increased saliva production
How to use Vexirab IT 20mg/150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vexirab IT 20mg/150mg Capsules. Administer on an empty stomach.
How Vexirab IT 20mg/150mg Capsule works:
Vexirab IT capsules (20mg/150mg) contain Rabeprazole, a proton pump inhibitor (PPI), and Itopride, a prokinetic agent. Rabeprazole lowers stomach acid production, easing acid indigestion and heartburn. Itopride stimulates brain regions regulating nausea and enhances upper gastrointestinal motility, facilitating smoother food passage through the digestive system.
SAFETY ADVICE
AlcoholCAUTION
Use of Vexirab IT 20mg/150mg Capsules with alcohol requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Vexirab IT 20mg/150mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Vexirab IT 20mg/150mg Capsule use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Using Vexirab IT 20mg/150mg Capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Vexirab IT 20mg/150mg Capsule use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vexirab IT 20mg/150mg capsules. Dosage modification of Vexirab IT 20mg/150mg capsules may be necessary. Physician consultation is advised.
What if you forget to take Vexirab IT 20mg/150mg Capsule :
Should you forget a Vexirab IT 20mg/150mg Capsule dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vexirab IT 20mg/150mg Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
